Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Established in 2004, ODC Therapy Inc. is a privately held company focused on the development and commercialization of active (vaccine) and passive (monoclonal antibody) immunotherapies for cancer. ODC has licensed a portfolio of intellectual property from Baylor Research Institute and Rockefeller University and has the option to license additional developments in cancer immunotherapy from Baylor Research Institute. Presently, ODC is seeking to raise capital through a Series A preferred offering. The Company’s cancer vaccines are produced by removing dendritic cell precursors from a patient’s bloodstream, culturing and loading the cells with tumor antigens and then reintroducing them back into the same ( www.odctherapy.com )
ODC Therapy , Inc.
3310 Live Oak Street Suite 401
Dallas, Texas 75204
USA
Tel: (214) 826-7019